Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Frontiers in Molecular Neuroscience|June 16, 2022
Transcriptional Activation, Deactivation and Rebound Patterns in Cortex, Hippocampus and Amygdala in Response to Ketamine Infusion in RatsJenny J Kim, Matthew R Sapio, Fernando A Vazquez, et al.
Frontiers in Oncology|December 11, 2024
Radiomic features of PET/CT imaging of large B cell lymphoma lesions predicts CAR T cell therapy efficacyYoganand Balagurunathan, Zhouping Wei, Jin Qi, et al.
Human Pathology|May 1, 2012
Immunoexpression status and prognostic value of mammalian target of rapamycin and hypoxia-induced pathway members in papillary cell renal cell carcinomasAlcides Chaux, Luciana Schultz, Roula Albadine, et al.
The Journal of Pain|April 23, 2021
The Persistent Pain Transcriptome: Identification of Cells and Molecules Activated by HyperalgesiaMatthew R Sapio, Jenny J Kim, Amelia J Loydpierson, et al.
Cancer Research and Treatment|March 13, 2015
Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?Daniel Keizman, Keren Rouvinov, Avishay Sella, et al.
Frontiers in Neuroscience|January 11, 2021
Comparative Analysis of Dorsal Root, Nodose and Sympathetic Ganglia for the Development of New AnalgesicsMatthew R Sapio, Fernando A Vazquez, Amelia J Loydpierson, et al.
Urology|April 10, 2014
Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder: a retrospective study of patients treated using radical cystectomyNilda Gonzalez-Roibon, Jenny J Kim, Sheila F Faraj, et al.
The American Journal of Surgical Pathology|September 2, 2011
Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomasLuciana Schultz, Alcides Chaux, Roula Albadine, et al.
Endocrinology|March 22, 2017
Incretin Therapies Do Not Expand β-Cell Mass or Alter Pancreatic Histology in Young Male MiceAaron R Cox, Carol J Lam, Matthew M Rankin, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Real-World Outcomes of Axicabtagene Ciloleucel for Treatment of Relapsed or Refractory Large B-Cell Lymphoma in CanadaChristopher Lemieux, John Kuruvilla, Mona Shafey, et al.
Pageof 6